Four Canadian cancer patients have been granted permission to use psilocybin as a treatment for end-of-life distress, a ground-breaking decision that may signal a broader future role for the hallucinogen in health care.
Federal Health Minister Patty Hajdu approved the use through the Office of Controlled Substances. The application was submitted more than 100 days ago.
Share this post
